Literature DB >> 14797744

Excretion of phenylalanine and derivatives in phenylpyruvic oligophrenia.

G A JERVIS.   

Abstract

Entities:  

Keywords:  OLIGOPHRENIA; PHENYLALANINE

Mesh：

Substances：

Year:  1950        PMID： 14797744     DOI： 10.3181/00379727-75-18108

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  Studies on phenylketonuria. I. Restricted phenylalanine intake in phenylketonuria.

Authors:  M D ARMSTRONG; F H TYLER
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  Diminished phenylketonuria in phenylpyruvic oligophrenia after administration of L-glutamine, L-glutamate or L-asparagine.

Authors:  A MEISTER; S UDENFRIEND; S P BESSMAN
Journal:  J Clin Invest       Date:  1956-06       Impact factor: 14.808

3.  [Congenital metabolic disorders].

Authors:  K SCHREIER
Journal:  Klin Wochenschr       Date:  1953-08-15

Review 4.  Hyperaminoaciduria in childhood.

Authors:  V N Ingle
Journal:  Indian J Pediatr       Date:  1966-02       Impact factor: 1.967

5.  A model of human phenylalanine metabolism in normal subjects and in phenylketonuric patients.

Authors:  S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Carriership of the rs113883650/rs2287120 haplotype of the SLC7A5 (LAT1) gene increases the risk of obesity in infants with phenylketonuria.

Authors:  Miroslaw Bik-Multanowski; Anna Madetko-Talowska; Iwona Betka; Elzbieta Swieczka; Bozena Didycz; Karolina Orchel-Szastak; Kinga Bik-Multanowska; Ewa Starostecka; Joanna Jaglowska; Renata Mozrzymas; Joanna Zolkowska; Katarzyna Chyz; Dorota Korycinska-Chaaban
Journal:  Mol Genet Metab Rep       Date:  2020-08-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.